Search - tctmd.com

Displaying 101 - 120 of 767

Sort: Relevancy | Date

Presentation TCT 2020

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment & Management of Stable Chest Pain

Presenter: Nick Curzen

October 16, 2020

Presentation TCT 2020

When, Why, and How to Evaluate the Microvasculature in the Cath Lab

Presenter: Tom Ford

October 16, 2020

Presentation TCT 2020

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

Presenter: Allen Jeremias

October 16, 2020

Presentation TCT 2020

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Presenter: David Erlinge

October 16, 2020

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

Presentation TCT 2020

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

Presenter: Robert Byrne

October 15, 2020

Presentation TCT 2020

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Presenter: Fernando Alfonso

October 15, 2020

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Presenter: Dean J. Kereiakes

October 15, 2020

Presentation TCT 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Presenter: Sripal Bangalore

October 15, 2020

Presentation TCT 2020

Critical Analysis and Clinical Implications From ISCHEMIA

Presenter: David Maron

October 15, 2020

Presentation TCT 2020

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

Presenter: Simon Walsh

October 15, 2020

Presentation TCT 2020

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Presenter: Luiz Ybarra

October 15, 2020

Presentation TCT 2020

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Presenter: Gerald Werner

October 15, 2020

Presentation TCT 2020

Device-Based Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

October 15, 2020

Advertisement

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment & Management of Stable Chest Pain

When, Why, and How to Evaluate the Microvasculature in the Cath Lab

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Clopidogrel for Most!

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Critical Analysis and Clinical Implications From ISCHEMIA

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Device-Based Approaches to Infarct Size Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content